Endocrinology and Pituitary Disorders
Clinical research includes management of microprolactinomas, with interest in prolactin normalization and treatment strategies for newly diagnosed patients.
- Microprolactinomas
- Hyperprolactinemia
- Pituitary surgery
The sponsor’s work in this area centers on comparing medical and surgical treatment pathways for pituitary-related disease.
Stroke and Secondary Prevention
Research activity covers non-cardioembolic ischemic stroke and long-term prevention of recurrent cardiovascular events through individualized antiplatelet use.
- Non-cardioembolic ischemic stroke
- Antiplatelet therapy
- Secondary prevention
Trials in this field address tailored treatment choices after stroke to reduce later vascular complications.
Thrombolysis Complications and Hemostasis
Investigations focus on ischemic stroke patients with post-rtPA hypofibrinogenemia and the prevention of hemorrhagic complications after thrombolytic treatment.
- Fibrinogen replacement
- Intracranial hemorrhage
- Bleeding complications
This area reflects interest in correcting coagulation disturbances linked to acute stroke care.
Critical Care and Septic Shock
Clinical studies include septic shock management in the intensive care unit, with attention to vasopressor selection and renal function outcomes.
- Septic shock
- Vasopressin
- Renal replacement therapy
The research portfolio in this domain is oriented toward hemodynamic support and organ protection in critically ill patients.
